Fifth Third Bancorp Bio Xcel Therapeutics, Inc. Transaction History

Fifth Third Bancorp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$10.25 - $22.43 $2,316 - $5,069	-226 Reduced 18.43%	1,000 $0
Q3 2022 Oct 25, 2022	BUY	$11.19 - $17.89 $2,528 - $4,043	226 Added 22.6%	1,226 $14,000
Q2 2022 Aug 04, 2022	SELL	$9.03 - $21.55 $1,056 - $2,521	-117 Reduced 10.47%	1,000 $13,000
Q3 2020 Nov 09, 2020	BUY	$37.44 - $64.63 $4,380 - $7,561	117 Added 11.7%	1,117 $48,000
Q1 2020 May 05, 2020	BUY	$12.26 - $41.14 $12,260 - $41,140	1,000 New	1,000 $22,000

3.12M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.53M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.